Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Rigel Pharmaceuticals
RIGL
$751M
| $392K | ﹤0.01% |
20,950
+4,038
| +24% | +$83.4K |
|
4352
American Coastal Insurance
ACIC
$533M
| $391K | ﹤0.01% |
27,933
+1,259
| +5% | +$16.2K |
|
4353
Foster
FSTR
$440M
| $391K | ﹤0.01% |
18,083
-2,207
| -11% | -$51.2K |
|
|
GES
4354
CALL
DELISTED
Guess Inc
GES
| $391K | ﹤0.01% |
21,100
-22,900
| -52% | -$380K |
|
4355
Prothena Corp
PRTA
$446M
| $391K | ﹤0.01% |
49,802
+6,984
| +16% | +$62K |
|
|
HTT
4356
CALL
High Templar Tech Ltd
HTT
$394M
| $391K | ﹤0.01% |
56,800
+2,000
| +4% | +$16.1K |
|
|
WTRE
4357
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $389K | ﹤0.01% |
14,411
+945
| +7% | +$23.1K |
|
4358
Digi International
DGII
$2.72B
| $388K | ﹤0.01% |
28,560
-3,778
| -12% | -$49.8K |
|
4359
El Pollo Loco
LOCO
$513M
| $388K | ﹤0.01% |
35,388
+10,220
| +41% | +$108K |
|
4360
Powell Industries
POWL
$7.75B
| $387K | ﹤0.01% |
29,670
-1,152
| -4% | -$14.3K |
|
4361
RadNet
RDNT
$5.29B
| $387K | ﹤0.01% |
26,971
-8,011
| -23% | -$117K |
|
4362
PUT
Winnebago Industries
WGO
$900M
| $387K | ﹤0.01% |
10,100
-23,000
| -69% | -$838K |
|
4363
Suburban Propane Partners
SPH
$1.17B
| $386K | ﹤0.01% |
16,347
-987
| -6% | -$23.3K |
|
4364
UNIFI
UFI
$122M
| $386K | ﹤0.01% |
17,586
-769
| -4% | -$15.2K |
|
|
FOCS
4365
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $384K | ﹤0.01% |
16,136
-13,356
| -45% | -$329K |
|
4366
CALL
GameStop
GME
$8.53B
| $383K | ﹤0.01% |
277,600
-721,600
| -72% | -$779K |
|
4367
Madrigal Pharmaceuticals
MDGL
$11.7B
| $383K | ﹤0.01% |
4,448
-593
| -12% | -$55.6K |
|
4368
ProShares Ultra S&P500
SSO
$8.31B
| $383K | ﹤0.01% |
23,856
-13,600
| -36% | -$216K |
|
|
CARO
4369
DELISTED
Carolina Financial Corp.
CARO
| $383K | ﹤0.01% |
10,782
-3,145
| -23% | -$110K |
|
4370
PUT
ZTO Express
ZTO
$17.9B
| $382K | ﹤0.01% |
17,900
+5,300
| +42% | +$107K |
|
4371
Lindblad Expeditions
LIND
$2.24B
| $381K | ﹤0.01% |
22,730
+1,653
| +8% | +$30.1K |
|
4372
MacroGenics
MGNX
$247M
| $381K | ﹤0.01% |
29,867
-2,904
| -9% | -$41.8K |
|
4373
NRC Health Common Stock
NRC
$437M
| $381K | ﹤0.01% |
6,594
-1,160
| -15% | -$71.9K |
|
|
DOVA
4374
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $381K | ﹤0.01% |
13,638
-32,686
| -71% | -$530K |
|
|
MDCO
4375
PUT
DELISTED
Medicines Co
MDCO
| $380K | ﹤0.01% |
7,600
+3,000
| +65% | +$120K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.